Phil Franchina, Author at American Parkinson Disease Association

Crexont®: A Newly Approved Parkinson’s Medication

Posted on August 8, 2024October 10, 2024 by Phil Franchina

New Carbidopa/Levodopa Formulation Approved for Reducing OFF Time Amneal Pharmaceuticals, Inc. announced today that their new medication IPX203, now known as...see more Crexont®, was approved by the Food and Drug Administration. Crexont is a novel oral formulation of carbidopa-levodopa extended-release capsules. Similar to Amneal’s Rytary, it contains both immediate-release and extended-release elements in the capsule and is designed […]

VICTORY FOR THE PARKINSON’S DISEASE COMMUNITY: THE NATIONAL PLAN TO END PARKINSON’S ACT IS NOW LAW

Posted on July 22, 2024August 8, 2024 by Phil Franchina

It’s official: The...see more President has signed The National Plan to End Parkinson’s Act into law! This is a momentous event for the PD community — and APDA is proud to have been a part of the efforts that made […]

WHAT’S HAPPENING AT APDA

Posted on July 22, 2024August 8, 2024 by Phil Franchina

Join us for an Optimism Walk! We’ve got a fantastic fall schedule of APDA Optimism...see more Walks and would love for you to come walk with us! Every Optimism Walk is an incredible day of community, inspiration, and family-friendly fun, all directly supporting APDA’s mission. Whether you start a team, register on […]

LEGOS FOR PARKINSON’S

Posted on July 22, 2024July 22, 2024 by Phil Franchina

As part of the FIRST* LEGO® League program, a group of students (11–13-year-olds) from South Carolina...see more calling themselves the “Argent Agents” developed three tools out of Legos that make it easier for people with Parkinson’s disease and essential tremors to use a paint brush, pencil, or marker so they can create art. […]

“ASK THE DOCTOR” WITH DR. REBECCA GILBERT

Posted on July 22, 2024July 22, 2024 by Phil Franchina

Q: I always seem to be nauseous. Are there treatments for this?...see more A: Nausea can be a side effect of carbidopa/levodopa, the most common and effective medication for PD. If this is the case, then try taking the medication with food. Some people find that dietary protein such […]

THE RISE OF BIOMARKER TECHNOLOGY IN PARKINSON’S DISEASE

Posted on July 22, 2024July 22, 2024 by Phil Franchina

A biomarker is a clue inside the body that indicates that...see more disease is present. A biomarker can be an imaging test, a biopsy, or a test on a body fluid such as blood or cerebral spinal fluid. Recently, there has been an abundance of news about biomarkers […]

AMERICAN PARKINSON DISEASE ASSOCIATION CELEBRATES THE NATIONAL PLAN TO END PARKINSON’S ACT BECOMING LAW

Posted on July 3, 2024August 28, 2024 by Phil Franchina

APDA remains steadfast in its mission to support those impacted by Parkinson’s disease as new law provides hope for...see more accelerated progress toward a cure NEW YORK, NY, JULY 3, 2024 – The American Parkinson Disease Association (APDA) is celebrating the President’s signing of the National Plan to End Parkinson’s Act yesterday, marking the enactment of […]

Historic News for the PD Community

Posted on July 3, 2024July 3, 2024 by Phil Franchina

The National Plan to End Parkinson’s Act Has Been Signed into Law Today we celebratethe President’s signing of the...see more National Plan to End Parkinson’s Act, marking the enactment of the first-ever federal legislation dedicated to curing and preventing Parkinson’s disease (PD) and ensuring quality care for those impacted by this chronic and progressive neurologic disease. […]

AMERICAN PARKINSON DISEASE ASSOCIATION ANNOUNCES NEW RESOURCES AVAILABLE IN MANDARIN & SIMPLIFIED CHINESE

Posted on June 24, 2024July 2, 2024 by Phil Franchina

APDA is Committed to Reaching & Supporting More People with Parkinson’s Disease NEW YORK, NY, JUNE 24, 2024 –...see more The mission of the American Parkinson Disease Association (APDA) is to provide the support, education, and research to help everyone impacted by Parkinson’s disease (PD) live life to the fullest. To promote health equality and access […]

Understanding levodopa-induced dyskinesias: APDA-funded research published

Posted on June 21, 2024June 21, 2024 by Phil Franchina

Congratulations to our 2020 APDA Research Grant Awardee Dr. Karen Jaunarajs for her work on understanding levodopa induced dyskinesias....see more Her study was recently published in Journal of Neuroscience. Dr. Jaunarajs works closely with Dr. David Standaert, Chairman of APDA’s Scientific Advisory Board, and the Chairman of University of Alabama at Birmingham’s Department of Neurology, which […]

What is Parkinson’s Disease?

Living with Parkinson’s Disease

Parkinson’s Resource Library

Research

Ways to Give

Crexont®: A Newly Approved Parkinson’s Medication

VICTORY FOR THE PARKINSON’S DISEASE COMMUNITY: THE NATIONAL PLAN TO END PARKINSON’S ACT IS NOW LAW

WHAT’S HAPPENING AT APDA

LEGOS FOR PARKINSON’S

“ASK THE DOCTOR” WITH DR. REBECCA GILBERT

THE RISE OF BIOMARKER TECHNOLOGY IN PARKINSON’S DISEASE

AMERICAN PARKINSON DISEASE ASSOCIATION CELEBRATES THE NATIONAL PLAN TO END PARKINSON’S ACT BECOMING LAW

Historic News for the PD Community

AMERICAN PARKINSON DISEASE ASSOCIATION ANNOUNCES NEW RESOURCES AVAILABLE IN MANDARIN & SIMPLIFIED CHINESE

Understanding levodopa-induced dyskinesias: APDA-funded research published

Support Our Mission

Support Our Mission

Subscribe to get updates from APDA and helpful Parkinson’s info!